Haoxi Health Technology Limited (HAO) Stock Overview
Explore Haoxi Health Technology Limited’s financial performance, market position, analyst ratings, and future outlook.
Haoxi Health Technology Limited (HAO)
Key Financials
Key Financials
Market Cap
9.5K
P/E Ratio
-1.43
EPS (TTM)
$-16.60
ROE
-0.17%
HAO Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Haoxi Health Technology Limited (NASDAQ: HAO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Haoxi Health Technology Limited's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of HAO on the NASDAQ shows an RSI of 21.96, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $0.18 for the NASDAQ listing.
Key metrics behind Haoxi Health Technology Limited's NASDAQ-traded stock include a P/E ratio of -1.43 and a market capitalization of 9.5K. Combined with our AI analysis, these give both institutional and retail investors a clear view of HAO on the NASDAQ.